LambdaVision has been selected by NASA for a Small Business Innovation Research (SBIR) Phase II award, worth $750,000 over two years.
With the continued support of NASA, LambdaVision will advance the development of its protein-based artificial retina.
“Throughout my 40-year career, I have explored the potential of using light-activated proteins in applications that include information processing, energy production, and visual restoration,” said LambdaVision Founder Robert R. Birge, PhD, Harold S. Schwenk Sr. Distinguished Chair Emeritus at the University of Connecticut.